SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| AstraZeneca | Pharmaceuticals, Biotechnology and Life Sciences | Europe | Targets set | Large | 5 | Oct 28, 2021 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year - Long-Term Status Targets set Net-Zero Status Targets set Net-Zero Year - Sector Pharmaceuticals, Biotechnology and Life Sciences Region Europe Organization Type Corporate Location United Kingdom Company Size Large Target Statement Global biopharmaceutical company AstraZeneca commits to reach net-zero greenhouse gas emissions across the value chain by FY2045. Near-Term Targets Global biopharmaceutical company AstraZeneca commits to reduce absolute scope 1 and 2 GHG emissions 98% by FY2026 from a FY2015 base… Stakeholders Jenny Perrie Scope 3 lead, Global Procurement Pam Cheng EVP, Global Operations, IT and Chief Sustainability Officer Director, Sustainable Procurement Nataša Vidmar Chief Procurement Officer Hamid Teimourian Energy Program (Sustainability) Lead | |||||||
Turn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.